Internal Medicine · West Orange, NJ
NPI
1710991187
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
741 Northfield Ave
West Orange, NJ, 07052
Phone (973) 325-3606
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
2,570 services
Medicare patients, 2024
554
Average age 76
Drug cost, 2024
$870K
10,339 prescriptions
Company payments, 2025
$1,922
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph S Cervone was code 99214 (office e&m - established), 598 times for 342 patients. In total Joseph S Cervone billed 2,570 services in 36 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 598 | 342 | $48.85 | $29K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 356 | 356 | $39.89 | $14K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 349 | 349 | $20.95 | $7,311 |
| 99497 Care Management/Coordination | Office | 219 | 219 | $26.02 | $5,698 |
| 99443 Telephone Services | Office | 215 | 160 | $93.31 | $20K |
| G0008 Administration of influenza virus vaccine | Office | 163 | 160 | $35.50 | $5,787 |
| 90662 Vaccine Product | Office | 155 | 153 | $81.37 | $13K |
| 93000 Electrocardiogram | Office | 147 | 142 | $10.68 | $1,570 |
| 99213 Office E&M - Established | Office | 116 | 97 | $44.41 | $5,152 |
| 90715 Vaccine Product | Office | 51 | 51 | $26.81 | $1,367 |
| 90471 Vaccine Administration | Office | 50 | 50 | $17.08 | $854 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 24 | 24 | $48.45 | $1,163 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 24 | 22 | $82.06 | $1,970 |
| 99215 Office E&M - Established | Office | 20 | 19 | $66.53 | $1,331 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 13 | 12 | $14.39 | $187 |
By year: 2022 $126K for 2,479 services; 2023 $126K for 2,556 services; 2024 $113K for 2,570 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph S Cervone prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,151 prescriptions and refills. In total Joseph S Cervone wrote 10,339 Medicare prescriptions that cost $870K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,151 | 3,381 | 351 | $12K |
| Amlodipine Besylate Generic | 378 | 1,096 | 118 | $2,189 |
| Hydrochlorothiazide Generic | 343 | 977 | 123 | $2,102 |
| Losartan Potassium Generic | 332 | 933 | 104 | $3,272 |
| Rosuvastatin Calcium Generic | 316 | 915 | 100 | $4,328 |
| Levothyroxine Sodium Generic | 316 | 931 | 94 | $4,575 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 308 | 876 | 85 | $5,921 |
| Ezetimibe Generic | 308 | 894 | 96 | $9,606 |
| Gabapentin Generic | 270 | 500 | 79 | $5,694 |
| Azelastine Hcl Generic | 257 | 444 | 153 | $6,751 |
| Metformin Hcl Generic | 217 | 569 | 66 | $2,078 |
| Metformin Hcl Er Metformin Hcl | 172 | 503 | 60 | $2,624 |
| Metoprolol Succinate Generic | 167 | 486 | 50 | $2,408 |
| Allopurinol Generic | 165 | 482 | 53 | $1,792 |
| Pantoprazole Sodium Generic | 159 | 388 | 52 | $2,078 |
Brand drugs: 1,114 claims; generic drugs: 9,178 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph S Cervone $1,922 ($1,922 in general payments such as food, travel and fees) from 22 companies. The largest payer was Novo Nordisk Inc with $231.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $231 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $203 |
| Amgen Inc. AMGN | 14 | $188 |
| Lilly USA, LLC LLY | 10 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $146 |
| Dexcom, Inc. DXCM | 6 | $132 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $125 |
| Pfizer Inc. PFE | 7 | $112 |
| Astellas Pharma US Inc 4503.T | 5 | $104 |
| Abbott Laboratories ABT | 4 | $90.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.